1IA
BSX icon

1620 Investment Advisors’s Boston Scientific BSX Stock Holding History

1620 Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32
Closed -$2.04K – 680
2026
Q1 		$2.04K Hold
32
– – ﹤0.01% 589
2025
Q4 		$3.09K Hold
32
– – ﹤0.01% 556
2025
Q3 		$3.17K Hold
32
– – ﹤0.01% 548
2025
Q2 		$3.48K Hold
32
– – ﹤0.01% 556
2025
Q1 		$3.27K Hold
32
– – ﹤0.01% 543
2024
Q4 		$2.9K Hold
32
– – ﹤0.01% 564
2024
Q3 		$2.72K Buy
+32
New +$2.52K ﹤0.01% 564

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

1620 Investment Advisors's BSX Position: Q2 2026 in Review

1620 Investment Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 32 shares — an estimated $2.04K sold.

1620 Investment Advisors first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $3.48K in Q2 2025. 424 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • 1620 Investment Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • 1620 Investment Advisors sold 32 Boston Scientific shares in Q2 2026, an estimated $2.04K.
  • 1620 Investment Advisors first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
  • 1620 Investment Advisors's Boston Scientific position peaked at $3.48K in Q2 2025.
  • 424 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.